Koala Health Files for IPO: Revolutionizing Chronic Pet Medication Management with a Digital Pharmacy Platform Covering 25,000 Clinics

In May 2025, pet health company Koala Health announced the completion of a $20 million Series B financing round led by Valspring Capital. The company focuses on providing integrated services for pet owners, including online consultations, offline medical navigation, and prescription drug delivery, with the aim of building a digital pet health management platform. This round of financing will not only accelerate the technological upgrade of its platform and further enhance its ability to connect pet owners with clinics, but also reflects that pet healthcare is becoming a hot emerging track in the field of digital health.

As pets assume a more prominent role in people’s lives, pet owners are placing increasing emphasis on health management. According to data from the American Pet Products Association (APPA), total U.S. household spending on pets reached $152 billion in 2024, with approximately $39.8 billion allocated to veterinary care and related services, accounting for more than one-quarter of the total.

However, current pet healthcare remains predominantly reliant on in-person visits, plagued by issues such as opaque pricing, long waiting times, and inconsistent quality of care. Particularly in areas like chronic disease management, continuity of medication, and follow-up guidance, traditional clinics struggle to meet the demand for high-frequency, personalized services.

Against this backdrop, related services are gradually transitioning from the “traditional clinic + offline pharmacy” model to a “online consultation + digital medication management” model.

Koala Health’s digital pharmacy platform (Figure 1) serves as a systematic response to the challenges associated with in-person veterinary visits. With over 14,000 user reviews and an impressive rating of 4.7 out of 5, the platform has become a trusted “intelligent medication management assistant” for pet owners.

Figure 1: Interface of the Koala Digital Pet Medication Platform

In actual operation, the platform primarily ensures a medication experience characterized by “high adherence and low interruption” through the following three core mechanisms:

Koala Health individually packages each pet medication by daily or per-dose units, with every packet clearly labeled with administration time, dosage, and instructions, effectively creating a dedicated “smart pillbox” for pets. This user-centric design significantly reduces the risk of dosing errors or missed doses caused by confusion over timing or amounts, proving particularly advantageous in cases involving multiple concurrent medications.

Koala Health has seamlessly integrated its platform with the e-prescribing systems of over 25,000 independent veterinary clinics across the United States, enabling users to obtain and update prescriptions online. Leveraging intelligent backend algorithms, the system monitors medication cycles in real time, automatically sends refill reminders, and issues restocking notifications or places automatic reorder requests based on inventory levels. This ensures continuity of care and minimizes the risk of medication interruptions.

Koala Health offers free medication delivery across all 50 U.S. states, with a consistent turnaround time of 1–2 days and no additional service fees. This efficient delivery system is particularly critical for pets with chronic conditions requiring continuous medication, significantly reducing the risk of treatment interruptions and supporting stable disease control and long-term management.

Notably, Koala Health’s pharmacy is accredited by the National Association of Boards of Pharmacy (NABP), ensuring compliance throughout the entire process of prescription review, drug procurement, and distribution, thereby providing a robust regulatory safeguard for its remote prescription renewal services.

As can be seen, Koala Health has not stopped at “efficiency improvement”; instead, by leveraging medication dispensing as a high-frequency touchpoint, it has built a long-term relational network between pet owners and clinics. By shifting from “one-time medication purchases” to “end-to-end companionship,” and from “medication distribution” to “disease management,” Koala Health has achieved “bilateral empowerment” in pet medication services: alleviating the operational burden on clinics while enhancing the medication experience for pet owners.

The three co-founders of Koala Health are not from the pet industry, but rather veterans in the “digital health” sector. They previously co-founded PillPack, a well-known U.S. chronic disease management platform that was acquired by Amazon for $1 billion in 2018. Through this experience, the team came to a profound realization: medication services—namely, “medication management”—constitute the “last mile” that determines long-term user retention and treatment outcomes.

When shifting the focus to the field of pet health, they identified the same issues, which are even more pronounced. Compared with the human healthcare system, medication management for pets lacks structured processes, which not only compromises treatment efficacy but also increases the operational burden on veterinary clinics. The team believes that rather than tackling the complex diagnostic and treatment chain, it is more effective to concentrate on the highly specialized and pain-point-intensive area of “medication administration,” leveraging digital tools to create a closed-loop service.

The founding team members bring complementary expertise, forming a tripartite capability portfolio encompassing technology, operations, and business development. CEO Gavin Cotter, formerly Vice President of Strategic Operations at PillPack, excels at enhancing service experience through supply chain optimization. Head of Technology Jordan Smith boasts 15 years of software development experience and specializes in building highly stable platforms. Co-founder Stephen Hendel previously led B2B pharmaceutical collaboration projects at the U.S. digital health company Blink Health, with extensive expertise in integrating pharmaceutical institutional workflows.

Over the past five years, Koala Health has achieved a leap from zero to nationwide coverage. This success was driven not by explosive traffic growth or subsidy-fueled expansion, but by steadily strengthening its foundational capabilities—ranging from technical architecture and logistics systems to pharmacy management and clinic partnership networks. With “deliberate” and “steady” as its guiding principles, Koala Health has carved out a digital pet healthcare path with significant long-term value.

Table 1: Koala Health Financing and Development Stages

Since its founding in 2021, Koala Health has not blindly pursued scale expansion; instead, it has remained focused on the “stability” and “depth” of its pet medication services—ensuring that every step from prescription to fulfillment is compliant, efficient, and controllable. From upgrading pharmacy systems and building cold-chain logistics to expanding its network of partner clinics, Koala spent two years solidifying its platform foundation to ensure that “every medication is delivered on time, accurately, and safely.”

This relentless pursuit of foundational stability has laid a solid groundwork for subsequent growth: on one hand, it has enhanced pet owners’ experience and strengthened clinic loyalty, preventing erosion of trust due to fulfillment issues; on the other hand, it has reduced systemic risks associated with scaling, enabling the platform to rapidly expand across all 50 U.S. states in 2023 and serve more than 25,000 clinics.

With its infrastructure in place and service network matured, Koala Health has shifted its strategic focus from “delivery efficiency” to “medication management services,” transitioning from one-off “drug sales” to a “long-term, companion-style health management” model centered on medication adherence, chronic disease management, and follow-up visit reminders. Accordingly, the platform’s capabilities have advanced from emphasizing “breadth of coverage” to deepening “service depth.”

Koala Health’s development path also offers valuable insights for the Chinese market, where some local platforms are actively exploring a digital service loop that transitions from “product sales” to “disease management.”

For instance, Boqi Pet partnered with Xunde Software to launch the “Yixin Yixuan” B2B marketplace, serving over 3,500 veterinary hospitals and promoting the digitalization of pharmaceutical supply chains, with ambitions to extend from drug distribution into prescription management and follow-up consultation scenarios. Mogu Pet Vet entered the field through remote consultations, focusing on prescription management and medication follow-ups, thereby creating an integrated closed-loop system that combines online consultations, offline clinical treatment, and medication purchases. Meanwhile, Chongyi Cloud has developed a comprehensive service platform covering pre-consultation, during-consultation, and post-consultation phases. It integrates features such as text-and-image consultations, video consultations, medical record management, health profiles, and vaccine reminders, while also enabling users to schedule grooming, bathing, vaccination, and deworming services via geolocation-based booking, gradually building a toolkit for full-cycle pet health management.

Despite varying approaches, these practices collectively point to a clear trend: platforms are evolving from merely “selling drugs” to “managing diseases,” shifting from one-time transactions to long-term health companionship, thereby driving the entire industry from product-driven to service-oriented.

The core of Koala Health’s growth lies not in aggressive expansion, but in the continuous refinement of its “closed-loop service” model. In this process, three key lessons offer valuable insights for Chinese enterprises:

First, the core of value escalation lies in shifting from “selling drugs” to “managing diseases.” After completing the construction of its pharmacy and logistics systems, Koala Health rapidly shifted its development focus toward pet chronic disease management and medication adherence services. It aims to upgrade from a mere drug-selling platform to a pet “health companion,” transforming user relationships from “transactional” to “managerial” and from “one-off” to “sustained.” This approach offers valuable lessons for Chinese platforms as well: they must transition from product-oriented to service-oriented models, extending into areas such as medication reminders, efficacy tracking, and chronic disease follow-ups, thereby building long-term user stickiness.

Second, strengthening core service capabilities proves more effective than blindly stacking features. Koala Health’s core advantage lies not in flashy features, but in the continuous optimization of medication fulfillment, prescription compliance, and delivery experience. While expanding their business modules, domestic platforms should also prioritize the stability of underlying systems, supply chain coordination, and the ongoing enhancement of user experience.

We believe that over the next three to five years, platforms capable of building Koala-style closed-loop capabilities while deeply rooting themselves in local scenarios for continuous refinement will be well-positioned to enter the “chronic disease management + continuous care” sector first, leading the next phase of digitalization in China’s pet health industry.